High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$133K
$133,549
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
NRIX
M
Nurix Therapeutics, Inc.
Hansen Gwenn
• Officer • Chief Scientific Officer
Other
2026-02-03
$26,320
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Other
|
2026-02-03 | $26,320 | M | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Hansen Gwenn
• Officer • Chief Scientific Officer
Sell to Cover
2026-01-30
$81,249x2
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2026-01-30 | $81,249x2 | S | Form 4 |
|
NRIX
S
Nurix Therapeutics, Inc.
Hansen Gwenn
• Officer • Chief Scientific Officer
Sell to Cover
2025-10-30
$52,300
|
||||||
| NRIX |
Nurix Therapeutics, Inc.
|
Officer • Chief Scientific Officer
Sell to Cover
|
2025-10-30 | $52,300 | S | Form 4 |